(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 3.3% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.27%.
Biote's revenue in 2025 is $199,073,000.On average, 7 Wall Street analysts forecast BTMD's revenue for 2025 to be $9,715,713,566, with the lowest BTMD revenue forecast at $9,227,258,192, and the highest BTMD revenue forecast at $10,076,122,439. On average, 7 Wall Street analysts forecast BTMD's revenue for 2026 to be $10,186,865,358, with the lowest BTMD revenue forecast at $9,086,851,991, and the highest BTMD revenue forecast at $11,030,291,337.
In 2027, BTMD is forecast to generate $10,915,098,926 in revenue, with the lowest revenue forecast at $9,830,411,589 and the highest revenue forecast at $11,939,470,925.